VIP and rheumatoid arthritis: The anti-RA effect of oral sinomenine can be summarized in the following order: (1) stimulation of α7nAChR; (2) activation the PI3K/Akt/mTOR pathway; and (3) generation of the anti-inflammatory neuropeptide VIP in the small intestine, which enters systemic circulation to regulate the inflammatory response pathway.